1. Home
  2. CSBR vs ASYS Comparison

CSBR vs ASYS Comparison

Compare CSBR & ASYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • ASYS
  • Stock Information
  • Founded
  • CSBR 1985
  • ASYS 1981
  • Country
  • CSBR United States
  • ASYS United States
  • Employees
  • CSBR N/A
  • ASYS N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • ASYS Industrial Machinery/Components
  • Sector
  • CSBR Health Care
  • ASYS Technology
  • Exchange
  • CSBR Nasdaq
  • ASYS Nasdaq
  • Market Cap
  • CSBR 90.2M
  • ASYS 83.0M
  • IPO Year
  • CSBR 1986
  • ASYS N/A
  • Fundamental
  • Price
  • CSBR $6.48
  • ASYS $7.49
  • Analyst Decision
  • CSBR Strong Buy
  • ASYS
  • Analyst Count
  • CSBR 1
  • ASYS 0
  • Target Price
  • CSBR $12.00
  • ASYS N/A
  • AVG Volume (30 Days)
  • CSBR 15.1K
  • ASYS 409.6K
  • Earning Date
  • CSBR 09-15-2025
  • ASYS 08-06-2025
  • Dividend Yield
  • CSBR N/A
  • ASYS N/A
  • EPS Growth
  • CSBR N/A
  • ASYS N/A
  • EPS
  • CSBR 0.21
  • ASYS N/A
  • Revenue
  • CSBR $56,878,000.00
  • ASYS $83,634,000.00
  • Revenue This Year
  • CSBR $7.31
  • ASYS N/A
  • Revenue Next Year
  • CSBR $12.01
  • ASYS $12.93
  • P/E Ratio
  • CSBR $30.18
  • ASYS N/A
  • Revenue Growth
  • CSBR 10.11
  • ASYS N/A
  • 52 Week Low
  • CSBR $3.75
  • ASYS $3.20
  • 52 Week High
  • CSBR $11.99
  • ASYS $10.80
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 47.59
  • ASYS 41.30
  • Support Level
  • CSBR $6.29
  • ASYS $8.76
  • Resistance Level
  • CSBR $6.79
  • ASYS $10.80
  • Average True Range (ATR)
  • CSBR 0.25
  • ASYS 0.87
  • MACD
  • CSBR 0.03
  • ASYS -0.35
  • Stochastic Oscillator
  • CSBR 33.83
  • ASYS 2.39

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About ASYS Amtech Systems Inc.

Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.

Share on Social Networks: